TucatinibTrastuzumab Emtansine
Dr. Dan Sotirescu, MD
NPI1942209234PAC ID3779546700
- Medicare services, 2024
- 109,465
- Medicare patients, 2024
- 818
- Part D claims, 2024
- 958
- Clinical trials
- 10
- MIPS score, 2024
- 100
- Practice address
- 25 Monument Road, Suite 270, York, PA 17403
- Practice phone
- Call (717) 741-8250
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Apple Hill Surgical Center
Surgery Center - Medicare-Certified · York, Pennsylvania
Find Dr. Sotirescu's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Dan Sotirescu is a hematologist and oncologist in York, Pennsylvania
Dr. Sotirescu practices at Apple Hill Surgical Center in York, Pennsylvania.
Dr. Sotirescu's NPI, 1942209234, was assigned on July 19, 2005. Dr. Sotirescu holds Pennsylvania license MD071718L.
NPI and contact details
- NPI
- 1942209234NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3779546700
- NPI enumeration date
- July 19, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (717) 741-8250
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 66
- Medical school graduation
- 1986
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Dan Sotirescu practices at Apple Hill Surgical Center in York, Pennsylvania
Dr. Sotirescu's primary practice is Apple Hill Surgical Center, at 25 Monument Road, Suite 270, York, PA 17403. The practice phone is (717) 741-8250.
- Apple Hill Surgical Center25 Monument Road, Suite 270, York, PA 17403Phone(717) 741-8250
Source: Dmand AI Affiliation Data
Dr. Dan Sotirescu is affiliated with 5 sites of care and 2 medical groups
Dr. Sotirescu's primary practice is Apple Hill Surgical Center in York, Pennsylvania. Dr. Sotirescu is also affiliated with WellSpan York Hospital. The medical group on file is WellSpan Digestive Health. Dmand AI also links Dr. Sotirescu to 1 more hospital, 1 group practice or clinic, 1 hospice and 1 medical group, each named with a free account.
Apple Hill Surgical CenterPrimary
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Dan Sotirescu's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sotirescu practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Apple Hill Surgical Center | Available with a free account |
| +4 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Sotirescu practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Dan Sotirescu is one of 645 hematologists and oncologists in Pennsylvania
Hematology and oncology is Dr. Sotirescu's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sotirescu is licensed in Pennsylvania.
Specialties and state licenses
- Hematology and oncology, PennsylvaniaPrimary
Hematologists and oncologists near Dr. Sotirescu
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Dan Sotirescu billed Medicare for 109,465 services in 2024
CMS data shows 109,465 Medicare services from Dr. Sotirescu across 70 procedure codes in 2024, for 818 Medicare patients. Medicare paid $1,782,020 for them.
Medicare services, 2024109,465
Medicare patients818
Paid by Medicare$1.8M
Procedure codes70
Dr. Sotirescu's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 81,4652024: 98,68421%
- Lab and pathology
- 2023: 3,1522024: 3,1941%
- Other services
- 2023: 7852024: 2,891268%
- Tests and treatments
- 2023: 1,9512024: 2,1028%
- Surgery
- 2023: 1,2972024: 1,4089%
- Office and hospital visits
- 2023: 1,0602024: 1,18612%
Where Dr. Sotirescu's Medicare services took place, 2024
- In an office109,402100%
- In a facility630%
Dr. Sotirescu compared with the Pennsylvania median for hematologists and oncologists, 2024
- Dr. Sotirescu
- Pennsylvania median
- Medicare services
- 109,465vs 654167.4 times
- Medicare patients
- 818vs 2273.6 times
- Part D claims
- 697vs 39377% above
Medians across 600 hematologists and oncologists in Pennsylvania with Dmand AI profiles that report each measure.
Dr. Sotirescu's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Sotirescu?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Sotirescu and other hematologists and oncologists in Pennsylvania.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Dan Sotirescu treated 818 Medicare patients in 2024, average age 75
CMS counts 818 Medicare patients who saw Dr. Sotirescu in 2024. The largest group is 65 to 74, with 320 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Sotirescu's median patient age at 72, with 47% women.
Medicare patients, 2024818
Average age75
Average risk score2.54
Also on Medicaid8%
Dr. Sotirescu's Medicare patients by age, 2024
Dr. Sotirescu's Medicare patients by sex, 2024
- Women43653%
- Men38247%
Chronic conditions among Dr. Sotirescu's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Cancer49%
- Arthritis48%
- Chronic kidney disease42%
- Ischemic heart disease39%
- Diabetes34%
- Anxiety33%
Share of Medicare patients with each condition. A patient can have several.
Dr. Sotirescu's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women47%
- Men52%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Dan Sotirescu wrote 958 Medicare Part D claims in 2024
In 2024, Dr. Sotirescu wrote 958 Medicare Part D claims for 211 patients. 82% of them were for generic drugs. CMS names the drug for 697 of them, across 18 drugs with 11 or more claims each, at $132,214 in total drug cost. In 2023, CMS named 687 claims across 20 drugs.
Part D claims, 2024958
Drugs named by CMS18
Total drug cost$132,214
Part D patients211
Dr. Sotirescu's Part D claims by kind of drug, 2024
- Generic789 claims82%
- Brand-name169 claims18%
Dr. Sotirescu's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Sotirescu's Part D claims, 2024
- Opioids3%29 of 958 claims
- Antibiotics2%17 of 958 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 6872024: 6971%
Drugs named by CMS: 18 in 2024, 20 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Dan Sotirescu scored 100 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Sotirescu for performance year 2024, reported individually. Dr. Sotirescu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sotirescu as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Sotirescu's MIPS scores, performance year 2024
- 100of 100Final score
- 95.5of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Sotirescu by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Dan Sotirescu has worked on 10 clinical trials
Dmand AI links Dr. Sotirescu to 10 clinical trials, 8 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Breast Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell and Breast Diseases. Alliance for Clinical Trials in Oncology sponsors the most, 5.
Clinical trials with Dr. Sotirescu by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 8Phase 3: 8 trials
- NonePhase 4: no trials
Conditions in Dr. Sotirescu's trials
- Breast Neoplasms
- Leukemia, Lymphocytic, Chronic, B-Cell
- Breast Diseases
- Leukemia, B-Cell
- Adenocarcinoma of Lung
Investigators on the most trials with Dr. Sotirescu
- Mark Leo Graham, MD4 shared trials
- Tyler Yu-Tai Kang, MD4 shared trials
- Jonathan D. King, MD4 shared trials
Recent clinical trials with Dr. Sotirescu
Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer (opens in a new tab)
Active, not recruitingPhase 2
Adenocarcinoma of LungCarcinoma, Non-Small-Cell LungPembrolizumabCarboplatinPemetrexed
Vitamin D3 with Chemotherapy and Bevacizumab in Treating Patients with Advanced or Metastatic Colorectal Cancer (opens in a new tab)
Active, not recruitingPhase 3
BevacizumabFluorouracilIrinotecan
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer (opens in a new tab)
Active, not recruitingPhase 3
Lung NeoplasmsThoracic NeoplasmsPembrolizumabCarboplatinPemetrexed
Breast NeoplasmsBreast Diseases
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Dan Sotirescu received $160,599 in industry payments from 2016 to 2025
CMS Open Payments shows 514 general payments to Dr. Sotirescu from 58 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 69% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $27,806.
General payments to Dr. Sotirescu by program year, 2016 to 2025
General payments to Dr. Sotirescu by kind, 2016 to 2025
$160.6Kin total
- Consulting fees$110,12069%
- Travel and lodging$26,03016%
- Food and beverage$9,4076%
- Speaker and faculty fees$8,5605%
- Other$6,4834%
Companies that paid Dr. Sotirescu the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Dan Sotirescu's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Dan Sotirescu
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Dan Sotirescu's NPI number?
Dr. Dan Sotirescu's NPI number is 1942209234. It was assigned on July 19, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Dan Sotirescu?
Dr. Dan Sotirescu is a hematologist and oncologist in York, Pennsylvania. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Dan Sotirescu practice?
Dr. Sotirescu practices at 25 Monument Road, Suite 270, York, PA 17403. Dr. Sotirescu's primary practice is Apple Hill Surgical Center in York, Pennsylvania. Dmand AI also links Dr. Sotirescu to 1 hospital, 1 group practice or clinic, 1 hospice and 1 medical group.
What is Dr. Dan Sotirescu's office phone number?
The practice phone on file for Dr. Sotirescu is (717) 741-8250.
What is Dr. Dan Sotirescu's medical license number?
Dr. Sotirescu holds Pennsylvania license MD071718L.
Which hospitals is Dr. Dan Sotirescu affiliated with?
Dr. Sotirescu is affiliated with WellSpan York Hospital. Dmand AI links Dr. Sotirescu to 1 more hospital.
What medical group is Dr. Dan Sotirescu part of?
Dr. Sotirescu is linked to WellSpan Digestive Health. Dmand AI links Dr. Sotirescu to 1 more medical group.
Does Dr. Dan Sotirescu accept Medicare?
Yes. CMS data shows Dr. Sotirescu billed Medicare for 109,465 services in 2024, and Dr. Sotirescu accepts Medicare assignment.
Does Dr. Dan Sotirescu offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Sotirescu as offering telehealth services.
What is Dr. Dan Sotirescu's MIPS score?
Dr. Sotirescu's MIPS final score for performance year 2024 is 100 out of 100, reported individually.
Show 6 more questionsShow fewer questions
How many Medicare patients does Dr. Dan Sotirescu see?
CMS counts 818 Medicare patients who saw Dr. Sotirescu in 2024, with an average age of 75.
What services does Dr. Dan Sotirescu bill to Medicare?
In 2024, Dr. Sotirescu's most billed Medicare services were injected or infused drug (J0881), injected or infused drug (J9144) and injected or infused drug (J9299).
What drugs does Dr. Dan Sotirescu prescribe most?
In 2024 Medicare Part D data, Dr. Sotirescu's most prescribed drugs by claims were Dexamethasone, Eliquis and Prochlorperazine Maleate.
Has Dr. Dan Sotirescu received payments from drug or device companies?
CMS Open Payments shows $160,599 in general payments to Dr. Sotirescu from 58 companies from 2016 to 2025. The largest total came from Bayer HealthCare Pharmaceuticals Inc.
How long has Dr. Dan Sotirescu been practicing?
Dr. Sotirescu graduated from medical school in 1986, 40 years ago.
Does Dr. Dan Sotirescu do research?
Dr. Sotirescu has worked on 10 clinical trials.
Selling to hematology and oncology practices?
See hematologists and oncologists in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card